A detailed history of Black Rock Inc. transactions in Codexis, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,789,379 shares of CDXS stock, worth $35.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,789,379
Previous 6,614,679 2.64%
Holding current value
$35.8 Million
Previous $23.1 Million 8.83%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.65 - $3.92 $462,955 - $684,824
174,700 Added 2.64%
6,789,379 $21 Million
Q1 2024

May 10, 2024

SELL
$2.59 - $4.65 $1.51 Million - $2.71 Million
-581,735 Reduced 8.08%
6,614,679 $23.1 Million
Q4 2023

Feb 13, 2024

SELL
$1.54 - $3.37 $302,565 - $662,107
-196,471 Reduced 2.66%
7,196,414 $21.9 Million
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.75 $1.18 Million - $2.96 Million
789,783 Added 11.96%
7,392,885 $14 Million
Q2 2023

Aug 11, 2023

BUY
$2.21 - $4.43 $1.22 Million - $2.45 Million
553,346 Added 9.15%
6,603,102 $18.5 Million
Q1 2023

May 12, 2023

SELL
$3.81 - $6.76 $400,724 - $710,996
-105,177 Reduced 1.71%
6,049,756 $25 Million
Q4 2022

Feb 13, 2023

BUY
$4.26 - $6.84 $2.87 Million - $4.61 Million
673,340 Added 12.28%
6,154,933 $28.7 Million
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $294,667 - $625,317
48,625 Added 0.89%
5,481,593 $33.2 Million
Q2 2022

Aug 12, 2022

BUY
$8.35 - $21.89 $2.08 Million - $5.46 Million
249,525 Added 4.81%
5,432,968 $56.8 Million
Q1 2022

May 12, 2022

BUY
$16.97 - $31.93 $653,243 - $1.23 Million
38,494 Added 0.75%
5,183,443 $107 Million
Q4 2021

Feb 10, 2022

SELL
$25.61 - $41.78 $2.52 Million - $4.11 Million
-98,333 Reduced 1.88%
5,144,949 $161 Million
Q3 2021

Nov 09, 2021

SELL
$19.65 - $27.99 $1 Million - $1.43 Million
-51,019 Reduced 0.96%
5,243,282 $122 Million
Q2 2021

Aug 11, 2021

BUY
$17.48 - $25.46 $92.5 Million - $135 Million
5,294,301 New
5,294,301 $120 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $346M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.